Clinic
Covenant Pediatrics PA
Covenant Pediatrics PA was paid $5.06M by Medicaid between Jan 2018 and Dec 2024, across 64 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 27% of everything it billed.
33Billing provider infoCOVENANT PEDIATRICS PA
MATTHEWS, NC 28105
MATTHEWS, NC 28105
33aNPI1932521630assigned 01/14/2014
33bProvider typePrimary Care Clinic/Center
28Total paid$5.06M
24GClaims213,723
24DCodes billed64
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in North Carolina
Rank by total paid#9 of 116
Median peer was paid$226K
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,004 | $513K | |
| 2019 | 14,814 | $513K | |
| 2020 | 13,611 | $498K | |
| 2021 | 27,872 | $763K | |
| 2022 | 52,037 | $1.03M | |
| 2023 | 43,244 | $943K | |
| 2024incomplete | 45,141 | $801K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 14,611 | 12,144 | $1.35M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 16,744 | 13,394 | $1.06M |
| 99199 | Unlisted special service, procedure or report | 9.9% | 86,226 | 51,448 | $500K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.4% | 3,508 | 3,066 | $323K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.6% | 3,087 | 2,779 | $286K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 3.8% | 5,281 | 4,405 | $194K |
| 86003 | 3.4% | 971 | 877 | $172K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.3% | 1,664 | 1,448 | $169K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.2% | 6,156 | 5,317 | $160K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.5% | 6,913 | 6,126 | $126K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.5% | 1,312 | 1,170 | $124K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2.2% | 3,542 | 3,193 | $109K |
52 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.8% | 6,840 | $91K |
| D0145 | Oral evaluation for a patient under three years of age | 1.4% | 2,139 | $69K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.2% | 5,924 | $62K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 1,572 | $58K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 907 | $40K |
| D1206 | Topical application of fluoride varnish | <1% | 2,137 | $30K |
| 69210 | <1% | 738 | $24K | |
| 96127 | <1% | 5,090 | $22K | |
| 87807 | <1% | 1,646 | $22K | |
| 81003 | <1% | 9,229 | $15K | |
| 90474 | <1% | 480 | $9K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,576 | $6K |
| 83655 | <1% | 400 | $5K | |
| 90651 | <1% | 290 | $5K | |
| 0071A | <1% | 79 | $5K | |
| 85018 | <1% | 2,338 | $4K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 42 | $3K |
| 92551 | <1% | 7,183 | $3K | |
| 0072A | <1% | 42 | $3K | |
| 90670 | <1% | 1,097 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 154 | $2K |
| 99173 | <1% | 7,826 | $1K | |
| 99441 | <1% | 69 | $1K | |
| 90686 | <1% | 921 | $995.60 | |
| 99383 | <1% | 15 | $935.68 | |
| 90734 | <1% | 91 | $809.45 | |
| 99442 | <1% | 20 | $730.61 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 35 | $545.49 |
| 97802 | <1% | 83 | $499.17 | |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 28 | $438.20 |
| 90620 | <1% | 74 | $386.10 | |
| 90723 | <1% | 550 | $363.68 | |
| 94664 | <1% | 28 | $311.98 | |
| 90649 | <1% | 55 | $268.74 | |
| 90633 | <1% | 509 | $178.98 | |
| 90715 | <1% | 80 | $86.76 | |
| 90688 | <1% | 33 | $70.04 | |
| 90656 | <1% | 348 | $49.74 | |
| 90647 | <1% | 799 | $29.84 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 12 | $0.81 |
| 90700 | 0% | 24 | $0.00 | |
| 90707 | 0% | 26 | $0.00 | |
| 90655 | 0% | 56 | $0.00 | |
| 90710 | 0% | 30 | $0.00 | |
| 90658 | 0% | 106 | $0.00 | |
| 91307 | 0% | 139 | $0.00 | |
| 90680 | 0% | 516 | $0.00 | |
| 90696 | 0% | 29 | $0.00 | |
| 90657 | 0% | 12 | $0.00 | |
| 99000 | 0% | 178 | $0.00 | |
| 90619 | 0% | 80 | $0.00 | |
| 36416 | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialEMEZIE, ANTHONIA (PRESIDENT)